TD Ameritrade Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-192
Closed -$10K 644
2021
Q3
$10K Buy
+192
New +$12.1K ﹤0.01% 440
2020
Q4
Sell
-192
Closed -$10K 638
2020
Q3
$10K Hold
192
﹤0.01% 440
2020
Q2
$9K Sell
192
-49
-20% -$2.64K ﹤0.01% 437
2020
Q1
$12K Buy
241
+56
+30% +$3.23K ﹤0.01% 399
2019
Q4
$10K Buy
185
+4
+2% +$217 ﹤0.01% 453
2019
Q3
$9K Buy
181
+18
+11% +$904 ﹤0.01% 444
2019
Q2
$8K Buy
+163
New +$7.91K ﹤0.01% 431

Other funds holding EHC

TD Ameritrade Investment Management's EHC Position: Q4 2021 in Review

TD Ameritrade Investment Management sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 192 shares — an estimated $10K sold.

TD Ameritrade Investment Management first reported a position in EHC in Q2 2019 and held it in 7 quarters. The position peaked at $12K in Q1 2020. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

  • TD Ameritrade Investment Management reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 192 Encompass Health shares in Q4 2021, an estimated $10K.
  • TD Ameritrade Investment Management first reported a position in Encompass Health in Q2 2019 and held it in 7 quarters.
  • TD Ameritrade Investment Management's Encompass Health position peaked at $12K in Q1 2020.
  • 409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on TD Ameritrade Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.